KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Amortization of Deferred Charges: 2009-2024

Historic Amortization of Deferred Charges for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $55.0 million.

  • Bausch Health Companies' Amortization of Deferred Charges rose 23.08% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.0 million, marking a year-over-year increase of 56.36%. This contributed to the annual value of $55.0 million for FY2024, which is 15.38% down from last year.
  • As of FY2024, Bausch Health Companies' Amortization of Deferred Charges stood at $55.0 million, which was down 15.38% from $65.0 million recorded in FY2023.
  • Bausch Health Companies' Amortization of Deferred Charges' 5-year high stood at $99.0 million during FY2022, with a 5-year trough of $55.0 million in FY2021.
  • Over the past 3 years, Bausch Health Companies' median Amortization of Deferred Charges value was $65.0 million (recorded in 2023), while the average stood at $73.0 million.
  • In the last 5 years, Bausch Health Companies' Amortization of Deferred Charges soared by 80.00% in 2022 and then plummeted by 34.34% in 2023.
  • Yearly analysis of 5 years shows Bausch Health Companies' Amortization of Deferred Charges stood at $61.0 million in 2020, then decreased by 9.84% to $55.0 million in 2021, then soared by 80.00% to $99.0 million in 2022, then slumped by 34.34% to $65.0 million in 2023, then fell by 15.38% to $55.0 million in 2024.